NCT07763574

Brief Summary

The purpose of the study is to evaluate the effects of 12-week supplementation with algae-derived DHA combined with strength training on muscle strength, neuromuscular parameters, post-exercise inflammation and cognitive functions in healthy adults compared to fish-derived EPA and DHA combined with strength training, strength training alone and control group. The research methods and measurement tools include:

  • Body composition assessed prior to the training intervention and after 12 weeks of training: body mass index (BMI) and body composition - fat mass \[kg\], body fat percentage \[%\] and skeletal muscle mass \[kg\] - will be determined using bioimpedance methods (In Body 720, Biospace, Seoul, Korea) following an overnight fast.
  • Assessment of physical activity levels using the long version of the International Physical Activity Questionnaire (IPAQ).
  • Assessment of mood (UMACL Adjective Mood Scale) and depression (DASS-21, Beck Depression Scale).
  • The SarQoL (Sarcopenia and Quality of Life) questionnaire, used to specifically assess quality of life in people with reduced muscle mass and function.
  • Assessment of participants' diet: each participant will be required to record their diet in 3-day food diaries (to be checked on the first day of testing).
  • Blood sampling: blood will be collected from each participant at two time points before and after the intervention (on an empty stomach, and 40 minutes after the training session). The following will be collected: 1 × 6 ml blood count tube and 3 tubes with a clotting activator, with a total volume of 20 ml. Blood will be collected before the start of the training intervention and after 12 weeks of training. The tubes will be centrifuged at 4 °C (4000 × g for 10 minutes). The serum, plasma and erythrocyte fractions will then be frozen at -80 °C until analysis.
  • Peak force, relative peak force and force at 150, 200 and 250 milliseconds during isometric mid-thigh pull-ups using a Kistler platform (Kistler dynamometer platform, model 9286BA, with MARS software). The maximum load (1RM) will also be measured for each participant. Upper limb grip strength will be measured using a SAEHAN electronic dynamometer.
  • In addition, muscle electrical activity using a Noraxon Telemyo surface electromyograph will be assessed.
  • Cognitive function will be assessed using the following tests: the Stroop Test, the Corsi Block-Tapping Task and the Pattern Separation Task. All analysis (beside IPAQ) will be performed before and after 12 weeks of intervention.
  • During the study, all participants will take part in a strength training session (around 40 mins duration) led by an experienced trainer to stimulate the muscles to release myokines.
  • Blood tests will include: BDNF, IGF-1, IL-6, hs-CRP, TNF-alpha, and IL-1B as well as concentrations of metabolites of the kynurenine pathway.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
41mo left

Started Aug 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 13, 2026

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 13, 2026

Completed
10 days until next milestone

Study Start

First participant enrolled

August 23, 2026

Expected
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2029

1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2030

Last Updated

August 13, 2026

Status Verified

August 1, 2026

Enrollment Period

2.4 years

First QC Date

July 13, 2026

Last Update Submit

August 12, 2026

Conditions

Keywords

algae-derived DHAomega-3 fatty acidsmuscle strength

Outcome Measures

Primary Outcomes (1)

  • Peak force (N), relative peak force (N/kg bw) and force at 150, 200, and 250 milliseconds (N) during Isometric Mid-Thigh Pull (IMTP) and Back Squat

    12 weeks intervention

Study Arms (6)

algae-derived DHA + strength training

EXPERIMENTAL

3g of a algae-derived DHA + strength training 3 times a week through 12 weeks

Dietary Supplement: Effects of Strength Training Combined With Omega-3s derived from algae on Muscle Strength and Cognitive Functions in adults

fish-derived omega-3 + strength training

EXPERIMENTAL

3g of a fish-derived omega-3 (EPA+DHA) + strength training 3 times a week through 12 weeks

Dietary Supplement: Effects of Strength Training Combined With Omega-3s derived from fish on Muscle Strength and Cognitive Functions in adults

placebo + strength training

PLACEBO COMPARATOR

3g of a placebo + strength training 3 times a week through 12 weeks

Dietary Supplement: Effects of Strength Training Combined With Placebo on Muscle Strength and Cognitive Functions in adults

algae-derived DHA without strength training

ACTIVE COMPARATOR

3g of a algae-derived DHA through 12 weeks

Dietary Supplement: Effects of Omega-3s derived from algae on Muscle Strength and Cognitive Functions in adults

fish-derived omega-3 without strength training

ACTIVE COMPARATOR

3g of a fish-derived omega-3 (EPA+DHA) through 12 weeks

Dietary Supplement: Effects of Omega-3s derived from fish on Muscle Strength and Cognitive Functions in adults

placebo without strength training

PLACEBO COMPARATOR

3g of a placebo through 12 weeks

Dietary Supplement: Effects of Placebo on Muscle Strength and Cognitive Functions in adults

Interventions

Healthy men and women with few years of training experience will participate in a 12-week strength training program combined with 3g/per day DHA from algae supplementation. The training will be 3 times a week, with 1-hour strength-training exercises for the upper and lower body. At the beginning and end of the intervention, muscle strength will be assessed along with EMG, cognitive function will be evaluated, and blood samples will be collected to measure specific proteins.

algae-derived DHA + strength training

Healthy men and women with few years of training experience will participate in a 12-week strength training program combined with EPA and DHA from fish supplementation (3g per day). The training will be 3 times a week, with 1-hour strength-training exercises for the upper and lower body. At the beginning and end of the intervention, muscle strength will be assessed along with EMG, cognitive function will be evaluated, and blood samples will be collected to measure specific proteins.

fish-derived omega-3 + strength training

Healthy men and women with few years of training experience will participate in a 12-week strength training program combined with placebo supplementation. The training will be 3 times a week, with 1-hour strength-training exercises for the upper and lower body. At the beginning and end of the intervention, muscle strength will be assessed along with EMG, cognitive function will be evaluated, and blood samples will be collected to measure specific proteins.

placebo + strength training

Healthy, untrained men and women will participate in a 12-week DHA from algae supplementation (3g per day). At the beginning and end of the intervention, muscle strength will be assessed along with EMG, cognitive function will be evaluated, and blood samples will be collected to measure specific proteins.

algae-derived DHA without strength training

Healthy, untrained men and women will participate in a 12-week EPA and DHA from fish supplementation (3g per day). At the beginning and end of the intervention, muscle strength will be assessed along with EMG, cognitive function will be evaluated, and blood samples will be collected to measure specific proteins.

fish-derived omega-3 without strength training

Healthy, untrained men and women will participate in a 12-week placebo supplementation. At the beginning and end of the intervention, muscle strength will be assessed along with EMG, cognitive function will be evaluated, and blood samples will be collected to measure specific proteins.

placebo without strength training

Eligibility Criteria

Age25 Years - 35 Years
Sexall(Gender-based eligibility)
Gender Eligibility Detailsmen who identify as men and women who identify as women
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • years of strength training experience,
  • without chronic or autoimmune diseases,
  • between the ages of 25 and 35,
  • not obese,
  • not taking omega-3 fatty acids,
  • not taking protein, BCAAs, creatine, anabolic steroids, or other supplements
  • for women: not pregnant or breastfeeding, and at least 1 year after childbirth (to allow for hormonal balance to stabilize).
  • For the control group (non-exercisers):
  • \- Requirements as above, except for exercise: we recruit individuals who exercise less than 1 hour per week

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Physical Education and Sport

Gdansk, Poland

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
A double-blind design will be employed. An independent researcher external to the research team will perform the randomization via www.randomizer.org. Based on the allocation list, this individual will distribute the omega-3 fatty acid capsules and placebos into identical bottles. Consequently, both the investigators and the participants will remain blinded to whether the active supplement or placebo is being administered.
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: A randomised, double-blind, controlled trial comprising six experimental arms receiving fish-derived omega-3 (EPA+DHA), algae-derived DHA, or a placebo, who are concurrently subjected to a 12-week resistance training intervention or no training, depending on group allocation.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 13, 2026

First Posted

August 13, 2026

Study Start (Estimated)

August 23, 2026

Primary Completion (Estimated)

January 1, 2029

Study Completion (Estimated)

January 1, 2030

Last Updated

August 13, 2026

Record last verified: 2026-08

Locations